PENTAMIDINE ISETHIONATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for pentamidine isethionate and what is the scope of patent protection?
Pentamidine isethionate
is the generic ingredient in four branded drugs marketed by Fresenius Kabi Usa, Seton Pharms, X-gen Pharms Inc, Armour Pharm, Avet Lifesciences, Baxter Hlthcare, Hospira, Watson Labs, and Xgen Pharms, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.There are thirteen drug master file entries for pentamidine isethionate. Four suppliers are listed for this compound.
Summary for PENTAMIDINE ISETHIONATE
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 9 |
| NDAs: | 11 |
| Drug Master File Entries: | 13 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 23 |
| Patent Applications: | 2,566 |
| Drug Prices: | Drug price trends for PENTAMIDINE ISETHIONATE |
| What excipients (inactive ingredients) are in PENTAMIDINE ISETHIONATE? | PENTAMIDINE ISETHIONATE excipients list |
| DailyMed Link: | PENTAMIDINE ISETHIONATE at DailyMed |
Recent Clinical Trials for PENTAMIDINE ISETHIONATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | Phase 1 |
| The Cleveland Clinic | Phase 1 |
| University of Texas Southwestern Medical Center | Phase 1 |
Pharmacology for PENTAMIDINE ISETHIONATE
| Drug Class | Antiprotozoal |
Medical Subject Heading (MeSH) Categories for PENTAMIDINE ISETHIONATE
Anatomical Therapeutic Chemical (ATC) Classes for PENTAMIDINE ISETHIONATE
US Patents and Regulatory Information for PENTAMIDINE ISETHIONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 213806-001 | Jan 7, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | NEBUPENT | pentamidine isethionate | FOR SOLUTION;INHALATION | 019887-001 | Jun 15, 1989 | AN | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 074303-001 | Aug 17, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Xgen Pharms | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 206982-001 | Mar 17, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
